NCT05627960: First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies |
|
|
| Recruiting | 1a | 77 | US | AG-01 Compound | A&G Pharmaceutical Inc., University of Maryland Greenebaum Cancer Center | Triple Negative Breast Cancer, Hormone-Resistant Breast Cancer, Non Small Cell Lung Cancer, Mesothelioma | 06/26 | 11/26 | | |